Orbital cellulitis and cavernous sinus thrombosis secondary to necrobacillosis.
Hegde
V
V
Mitry
D
D
Mc Ateer
D
D
Azuara-Blanco
A
A
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002426:Cavernous Sinus; D002481:Cellulitis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D005674:Fusobacterium Infections / Q000150:complications* / Q000188:drug therapy; D005675:Fusobacterium necrophorum / Q000302:isolation & purification*; D006801:Humans; D009916:Orbital Diseases / Q000188:drug therapy / Q000382:microbiology*; D013927:Thrombosis / Q000188:drug therapy / Q000382:microbiology*; D016896:Treatment Outcome; D055815:Young Adult
D000900:Anti-Bacterial Agents